Stock Scorecard



Stock Summary for Procept BioRobotics Corp (PRCT) - $23.87 as of 2/27/2026 6:52:39 PM EST

Total Score

11 out of 30

Safety Score

40 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PRCT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PRCT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PRCT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PRCT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PRCT (40 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PRCT

Truist cuts Procept BioRobotics stock price target on lower forecasts 2/27/2026 6:51:00 PM
PROCEPT BioRobotics (PRCT) Quarterly Loss Deepens Challenging Bullish Margin Expansion Narrative 2/27/2026 12:53:00 AM
Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation 2/26/2026 9:53:00 PM
Westfield Capital Management Co. LP Raises Stake in PROCEPT BioRobotics Corporation $PRCT 2/26/2026 1:53:00 PM
Robot surgery firm targets BPH leadership and eyes prostate cancer market 2/26/2026 12:53:00 PM
PROCEPT BioRobotics to Host Investor Day, Issues 2026 Guidance and Updates on HYDROS & Aquablation Growth 2/26/2026 12:53:00 PM
BofA downgrades Procept BioRobotics stock rating on utilization concerns 2/26/2026 11:53:00 AM
PRCT Stock Tumbles Pre-Market: BofA Questions Earnings Visibility, Cuts Target To $20 2/26/2026 11:31:00 AM
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance 2/26/2026 3:51:00 AM
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.21 EPS 2/25/2026 10:52:00 PM

Financial Details for PRCT

Company Overview

Ticker PRCT
Company Name Procept BioRobotics Corp
Country USA
Description PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. The company is headquartered in Redwood City, California.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date 3/3/2026

Stock Price History

Last Day Price 23.87
Price 4 Years Ago 41.54
Last Day Price Updated 2/27/2026 6:52:39 PM EST
Last Day Volume 9,027,936
Average Daily Volume 1,249,810
52-Week High 66.85
52-Week Low 26.23
Last Price to 52 Week Low 9.00%

Valuation Measures

Trailing PE N/A
Industry PE 45.58
Sector PE 46.86
5-Year Average PE -23.69
Free Cash Flow Ratio 4.53
Industry Free Cash Flow Ratio 26.39
Sector Free Cash Flow Ratio 25.71
Current Ratio Most Recent Quarter 8.43
Total Cash Per Share 5.27
Book Value Per Share Most Recent Quarter 6.81
Price to Book Ratio 5.02
Industry Price to Book Ratio 4.96
Sector Price to Book Ratio 52.77
Price to Sales Ratio Twelve Trailing Months 5.08
Industry Price to Sales Ratio Twelve Trailing Months 4.39
Sector Price to Sales Ratio Twelve Trailing Months 22.39
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 55,879,000
Market Capitalization 1,333,831,730
Institutional Ownership 104.66%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -4.55%
Reported EPS 12 Trailing Months -1.53
Reported EPS Past Year -1.18
Reported EPS Prior Year -1.76
Net Income Twelve Trailing Months -95,571,000
Net Income Past Year -95,573,000
Net Income Prior Year -91,413,000
Quarterly Revenue Growth YOY 42.80%
5-Year Revenue Growth 109.04%
Operating Margin Twelve Trailing Months -27.80%

Balance Sheet

Total Cash Most Recent Quarter 294,281,000
Total Cash Past Year 333,725,000
Total Cash Prior Year 257,221,999
Net Cash Position Most Recent Quarter 242,715,000
Net Cash Position Past Year 282,253,000
Long Term Debt Past Year 51,472,000
Long Term Debt Prior Year 51,339,000
Total Debt Most Recent Quarter 51,566,000
Equity to Debt Ratio Past Year 0.89
Equity to Debt Ratio Most Recent Quarter 0.88
Total Stockholder Equity Past Year 402,220,000
Total Stockholder Equity Prior Year 280,752,000
Total Stockholder Equity Most Recent Quarter 380,276,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -79,729,000
Free Cash Flow Per Share Twelve Trailing Months -1.43
Free Cash Flow Past Year -103,622,000
Free Cash Flow Prior Year -133,209,000

Options

Put/Call Ratio 0.58
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -1.57
MACD Signal -1.08
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.98
RSI 21.54
50-Day SMA 43.39
150-Day SMA 50.79
200-Day SMA 47.80

System

Modified 2/26/2026 6:32:52 AM EST